Board Meetings for ASTRAZEN
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| ASTRAZEN | AstraZeneca Pharma India Limited | 02 Feb 2012 | Un-audited Financial Results | Inter alia, to consider and approve the unaudited financial results of the Company for the quarter ended December 31, 2011. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 10 Nov 2011 | Un-audited Financial Results | Inter alia, to consider and approve the unaudited financial results of the Company for the quarter and half year ended September 30, 2011. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 08 Aug 2011 | Un-audited Financial Results | Inter alia, to consider and approve the unaudited financial results of the Company for the quarter ended June 30, 2011. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 14 Jun 2011 | Miscelleneous | Inter alia to consider and approve the proposal of straightening of land boundaries of factory with IDL Industries Limited. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 13 May 2011 | Results/Dividend | Inter alia to consider and approve the Audited Financial Results of the Company for the quarter and financial year (15 Months) ended March 31, 2011 and to recommend dividend, if any. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 08 Feb 2011 | Un-audited Financial Results | Inter alia, to consider and approve the unaudited financial results of the Company for the quarter ended December 31, 2010. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 27 Oct 2010 | Un-audited Financial Results | Inter alia, to consider and approve the unaudited financial results of the Company for the quarter ended September 30, 2010. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 27 Jul 2010 | Postal Ballot | The Board shall inter-alia, consider seeking approval of the shareholders of the Company through postal ballot, pursuant to Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009, in connection with the delisting proposal initiated by AstraZeneca Pharmaceuticals, AB, Sweden, promoter of the Company. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 27 Jul 2010 | Un-audited Financial Results | Inter alia, to consider and approve the un-audited financial results of the Company for the quarter and six months ended June 30, 2010. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 09 Jul 2010 | Postal Ballot | Inter alia, to consider seeking approval of Shareholders of the Company through postal ballot, pursuant to Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009, in connection with the delisting proposal initiated by AstraZeneca Pharmaceuticals AB, Sweden, promoter of the Company. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 29 Jun 2010 | Voluntary Delisting | The Company has inform the Exchange that the Board of Directors (Board) of AstraZeneca Pharma India Limited (Company) have received a letter from AstraZeneca Pharmaceuticals AB (AP AB), promoter of the Company, on June 28, 2010, proposing to make a voluntary delisting offer (the Delisting Offer) to the public shareholders of the Company in accordance with the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009 (Delisting Regulations) with a view to delist the equity shares of the Company from Bombay Stock Exchange (BSE), National Stock Exchange of India Limited (NSE) and Bangalore Stock Exchange Limited (BgSE) (collectively, Stock Exchanges), being the stock exchanges on which the equity shares are currently listed (the Delisting Proposal) under the Delisting Regulations. | |
| ASTRAZEN | AstraZeneca Pharma India Limited | 26 Apr 2010 | Unaudited Financial Results | Inter-alia, to consider and approve the unaudited financial results of the Company for the quarter ended March 31, 2010. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 25 Mar 2010 | Miscellaneous | The Special meeting of the Board of Directors of the Company will be held on March 25, 2010, inter alia, to consider a proposal for augmenting the Company's existing manufacturing facility. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 23 Feb 2010 | Audited Financial Results and Dividend | Inter alia to consider and approve the Audited Financial Results of the Company for the last quarter and financial year ended December 31, 2009 and to recommend dividend, if any. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 27 Oct 2009 | Unaudited Financial Results for the Qtr ended Sept 30, 2009 | - | - |